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ABSTRACT: The world's worst chemical industrial disaster, which occurred at
Bhopal on 2–3 December, 1984, resulted in considerable respiratory morbidity in
the exposed population. Therefore, a study was planned to evaluate the relation-
ship between lower respiratory tract inflammation, lung function and severity of
exposure.
Sixty patients exposed to methyl isocyanate and presenting with respiratory
symptoms were studied using bronchoalveolar lavage (BAL) 1–7 yrs after the acci-
dent. Pulmonary function tests included forced vital capacity (FVC) and forced
expiratory volume in one second (FEV1). An index of severity of exposure was
derived retrospectively on the basis of the acute symptoms in the victims them-
selves or the occurrence of death among their family members.
Total lung inflammatory cells (p<0.01) and absolute numbers of macrophages
(p=0.01) and lymphocytes (p<0.05) increased as severity of exposure increased.
FEV1/FVC % (p=0.05) was also significantly lower as severity of exposure increased.
Moderately exposed subjects had significantly lower FEV1/FVC % (p<0.05) com-
pared to those mildly exposed.
In nonsmokers, BAL neutrophils, both percentage and absolute numbers, showed
significant negative correlations with FEV1 % predicted (rs=-0.350, p<0.05; and rs=
-0.374, p<0.01, respectively). Neutrophil percentage was negatively correlated with
FEV1/FVC % (rs= -0.378; p<0.01). Absolute lymphocytes had significant negative
correlations with FVC % pred (rs= -0.318; p<0.05). Macrophages had significant
positive correlations with FVC % pred (rs=0.322; p<0.05) and FEV1 % pred(rs=0.433; p<0.01). Radiographic abnormalities (International Labour Organization(ILO) classification) were associated with decline in FEV1 % pred (p<0.05).
This study suggests that pulmonary function abnormalities occur in gas-exposed
subjects as a consequence of an abnormal accumulation of lung inflammatory cells
(lymphocytes and neutrophils), and that the intensity of lung inflammation and
reduction in pulmonary function are greater in severely exposed subjects. As it
has been observed that decline in pulmonary function is associated with radio-
graphic abnormalities, there is a suggestion that injury following toxic gas expo-
sure can lead to irreversible lung damage.
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Bronchoalveolar lavage (BAL) studies in toxic gas ex-
posed subjects at Bhopal revealed that initial macrophage
alveolitis had progressed to macrophage-neutrophilic
alveolitis as time passed [1, 2]. It had also been shown
that there was an abnormally elevated fibronectin level
in 30% of subjects exposed to the toxic gas [2]. These
findings suggest that the macrophage-neutrophilic alveo-
litis in toxic gas exposed subjects may cause pulmonary
injury and fibrosis, and result in impairment of lung
function, as it has been reported that activated lung in-
flammatory cells, including macrophages, lymphocytes,
neutrophils and eosinophils, are capable of releasing
toxic mediators and injuring lung parenchyma in vari-
ous interstitial lung diseases [3]. It is also possible that
the intensity of inflammation (alveolitis) will be greater
in subjects severely exposed to toxic gas compared to
mildly and moderately exposed subjects. As we have pre-
viously reported the BAL cell profiles that characteri-
zed the lower respiratory tract inflammation in these
subjects [1, 2], this study evaluates the relationship of
cells comprising alveolitis with changes in lung func-
tion and severity of exposure in toxic gas victims at
Bhopal.
Subjects and methods
Sixty patients (54 males and 6 females, aged 18–60
yrs) with a history of exposure to toxic gas on 2–3 Dec-
ember, 1984, and presenting with respiratory symptoms
were included in the study [1, 2]. The study was car-
ried out 1–7 yrs after the accident. The main present-
ing symptoms were cough and dyspnoea on exertion.
Patients were selected partly from the out-patient clinic
exclusively established for toxic gas victims at Hamidia
Hospital, Bhopal, and partly from the patients' homes
which were visited by VKV. Patients with a previous
history of respiratory disease prior to exposure were
excluded. Even though a large number of patients were
selected for BAL study, only a minority of patients were
willing to undergo the procedure. Each individual was
evaluated with a detailed history, physical examination,
a full plate posteroanterior (PA) chest radiograph, total
and differential leucocyte counts in peripheral blood,
and a 12-lead electrocardiogram. An experienced chest
physician read all chest radiographs using the modified
International Labour Organization (ILO) classification
[4].
Pulmonary function tests
Pulmonary function tests, including forced vital capac-
ity (FVC), forced expiratory volume in one second (FEV1)
and the ratio of FEV1 to FVC, were carried out using
transfer test Model C (PK Morgan Ltd, Chatham, UK).
Since the number of patients who had lung volumes and
carbon monoxide transfer factor measured in this study
was small, these data were not included. FVC and FEV1
were determined from the best two of three acceptable
forced vital capacity manoeuvres varying by not more
than ±5% [5]. The largest FVC and FEV1 values cor-
rected for body temperature atmospheric pressure and
saturation with water vapour (BTPS) were recorded,
even if the two values did not come from the same
curve. Pulmonary function results were classified as
obstructive and restrictive ventilatory defects using the
criteria of MILLER et al. [6]. An obstructive ventilatory
defect was defined as the FEV1/FVC less than 75% and
FVC more than 75% predicted. A restrictive ventilatory
defect was defined as the FEV1/FVC more than 75% and
FVC less than 75% pred. Pulmonary function results were
compared with the regression equations established for
North Indian subjects [7, 8].
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) was performed with a
flexible fibreoptic bronchoscope as described previous-
ly [1], and was carried out in all patients within 3 days
following pulmonary function tests. Bronchoscopies and
BAL were performed under local anaesthesia. Since
there was no radiographic localization of disease in the
gas-exposed subjects and there was a possibility that the
gas might have entered all lobes of the lung, BAL was
performed from three sites. Briefly, five 20 mL aliquots
of normal saline at room temperature were instilled into
each lobe and recovered immediately using suction with
50–100 mmH2O negative pressure, the bronchoscope
being wedged in a subsegmental bronchus of the right
middle lobe, lingula and left lower lobe. The fluid was
filtered through gauze to remove mucus and was pooled.
An aliquot was used for filter preparations. The total
number of cells was estimated using a haemocytometer
and expressed as cells·dL-1. Filter preparations were
made on pooled lavage fluid (uncentrifuged cells) as re-
ported by SALTINI et al. [9], and were stained using hae-
matoxylin and eosin stain. A minimum of 400 cells was
counted on each slide by two experienced observers
(VKV, KS) and recorded independently. Both observers
agreed to within 5% on all lavage analysis and the mean
value was used for analysis. BAL were also performed
in 17, normal nonsmoking subjects from Madras as con-
trols. Normal subjects from Madras were studied during
the same period because of the difficulty in selection and
in obtaining consent for BAL from normal subjects from
Bhopal. None of these subjects had respiratory symp-
toms or abnormal physical findings, and all had normal
chest radiographs and normal pulmonary function.
Classification of severity of exposure
As the degree of exposure to the gas may not be the
same in all individuals, the patients were categorized
into three groups depending upon the severity of expo-
sure. The three categories were as follows:
Severe exposure. If one member of the family had died
due to toxic gas exposure or the patient had severe oph-
thalmic and respiratory symptoms, including unconsci-
ousness on the day of exposure, requiring immediate
hospitalization the patient was classified as having had
severe exposure.
Moderate exposure. Patients with respiratory and oph-
thalmic symptoms on the day of exposure requiring only
out-patient management were classified as having had
moderate exposure.
Mild exposure. Patients with mild respiratory symptoms
on the day of exposure, and not seeking immediate medi-
cal relief because of mild symptoms, were classified as
having had mild exposure.
Statistical analysis
All data are expressed as mean±SD. BAL results in nor-
mal subjects and patients were compared using Mann-
Whitney U-test. Pulmonary function results were compared
with predicted values using Student's t-test. The rela-
tionship between BAL cells and pulmonary function was
analysed using Spearman's rank correlation. BAL and
pulmonary function results between groups (mild, mod-
erate and severe exposure) were compared using one-
way analysis of variance (ANOVA). Tukey's modified
t-test (Honestly Significant Difference (HSD) procedure)
was also employed to analyse the relationship of expo-
sure class (mild, moderate, severe) with BAL cells and
pulmonary function. Stepwise logistic regression was
used to determine the relationship between radiograph-
ic findings, BAL cell profile and pulmonary function.
The relationship between time elapsed since exposure
and outcomes (pulmonary function and BAL cells) was
analysed using multiple regression.
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Results
The mean age of the subjects studied was 35±10 yrs
(range 18–60 yrs). The physical characteristics of the
study groups are presented in table 1. BAL was perfor-
med 2.8±1.9 yrs (range 1–7 years) after exposure. There
were six patients with mild exposure, 13 with moder-
ate exposure and 41 with severe exposure. All severely
exposed patients were hospitalized immediately after
exposure to the toxic gas on 3 December, 1984. All mild-
ly exposed (n=6) and moderately exposed (n=13) sub-
jects were nonsmokers. Ten severely exposed patients
were smokers. At the time of the present study, rhonchi
and/or rales were heard in 11 patients (severe 8, mode-
rate 3, mild 0). All mildly exposed patients had normal
chest radiographs and pulmonary function. Seven of 13
moderately exposed patients had radiographic abnorma-
lity of 1/0 or 1/1 (ILO, 1980 classification) [4], and six
had obstructive ventilatory defect. Radiographic abnor-
malities of 1/0 to 2/2 were observed in 29 of 41 severe-
ly exposed patients. Eleven had obstructive and eight
had restrictive ventilatory defects in the severely exposed
group. Overall, the mean FVC (observed vs predicted
3.17±0.85 vs 3.7±0.6 L; p<0.001) and mean FEV1 (ob-
served vs predicted 2.52±0.78 vs 3.0±0.4 L; p<0.001)
were significantly lower in subjects exposed to toxic
gas compared to predicted values [7, 8]. In control sub-
jects, the mean FVC (observed vs predicted 3.08±0.59 vs
3.16±0.52 L; p>0.2) and mean FEV1 (observed vs pre-
dicted 2.70±0.59 vs 2.81±0.54 L; p>0.2) were similar
to those of predicted values [10]. Total and differential
leucocyte counts in peripheral blood and electrocardio-
grams were within normal limits in all subjects studied.
As reported previously in these subjects [1, 2], severe-
ly exposed patients had a significantly elevated total cell
count (p<0.01) in the lower respiratory tract compared
to normals and was true whether all individuals or only
severely exposed nonsmokers were considered (fig. 1).
BAL fluid recoveries were similar in all patient groups
(mild 50.1±9.8%, moderate 49.8±10.8% and severe 49.6
± 12.1%), but were higher in control subjects (60.7%).
Among the inflammatory and immune effector cells re-
covered from the lower respiratory tract, there was a
significant rise in alveolar macrophages (p<0.01) and
neutrophils (p<0.01) in severely exposed compared to
normal subjects. Similar findings of a significant rise in
alveolar macrophages (p<0.01) and neutrophils (p<0.01)
were seen in severely exposed nonsmokers compared to
normal subjects (fig. 1).
Pulmonary function in relation to severity of exposure
One-way ANOVA of pulmonary function in relation
to severity of exposure revealed that FEV1/FVC %
declined significantly (p=0.05) as severity of exposure
increased (fig. 2). FEV1 % pred showed a declining
trend, though it did not attain statistical significance
(p=0.09). FEV1/FVC % (p=0.07) and FEV1 % pred (p=
0.09) also showed a declining trend in nonsmokers.
Tukey's modified t-test showed that FEV1/FVC % in
mildly exposed subjects was significantly different (p<
0.05) from those moderately exposed. There was no dif-
ference in pulmonary function between moderately and
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Table 1.  –  Physical characteristics of study subjects
n Age Height Weight
yrs cm kg
Mild exposure 6 35±7 168±6 51±6
Moderate exposure 13 35±8 166±9 53±12
Severe exposure 41 35±11 162±8 52±9




















Fig. 1.  –  BAL findings in relation to severity of exposure. Mann-Whit-
ney U-test: total cells (p<0.01), macrophages (p<0.01) and polymorphs
(p<0.01) were significantly higher in severely exposed nonsmokers
and smokers compared to control subjects. One-way ANOVA: All sub-
jects: total cells (p<0.01), macrophages (p=0.02) and lymphocytes
(p=0.05) increased as severity of exposure increased. Nonsmokers:
total cells (p<0.01), macrophages (p=0.01) and lymphocytes (p<0.05)
increased as severity of exposure increased.  Tukey's modified t-test:
severely exposed (all subjects and nonsmokers) had higher total cells
(p<0.05) and macrophages (p<0.05) compared to mildly exposed sub-
jects. BAL: bronchoalveolar lavage; NS: nonsmoker; SM: smoker;
ANOVA: analysis of variance.        : neutrophils;        : lympho-













Fig. 2.  –  Pulmonary function results in relation to severity of expo-
sure. One-way ANOVA: FEV1/FVC % declined as severity of expo-
sure increased (p=0.05). FEV1: forced expiratory volume in one second;
FVC: forced vital capacity; NS: nonsmoker; SM: smoker; ANOVA:
analysis of variance.         : FVC % predicted;          : FEV1 % pre-
dicted;          : FEV1/FVC %.
severely exposed subjects. Seventeen patients (moder-
ate 6 and severe 11) had obstructive ventilatory defect
and eight severely exposed had restrictive ventilatory
defect.
BAL findings in relation to severity of exposure
Comparisons of BAL cell differential percentages and
absolute counts were made between patients with three
grades of severity of exposure. One-way ANOVA dem-
onstrated that total cells (p<0.01), absolute macrophages
(p=0.02) and absolute lymphocytes (p=0.05) increased
significantly as severity of exposure increased. A simi-
lar trend was observed in nonsmokers (total cells, p<0.01;
absolute macrophages, p=0.01; absolute lymphocytes,
p<0.05). Tukey's modified t-test revealed that total cells
(p<0.05) and absolute macrophages (p<0.05) were sig-
nificantly different in mildly exposed subjects from those
in severely exposed subjects (fig. 1). There were no dif-
ferences in total cells and absolute macrophages bet-
ween mildly exposed and moderately exposed groups;
and between moderately and severely exposed groups.
The findings were similar in nonsmokers. The interval
between the time of exposure and BAL study was sig-
nificantly shorter (p<0.05) in mildly exposed (1.25±0.3
yrs) and severely exposed (2.77±1.8 yrs) compared to
moderately exposed (4.21±2.2 yrs) subjects (Tukey's
modified t-test). In nonsmokers, this interval was sig-
nificantly shorter in mildly exposed (p<0.05) compared
to moderately and severely exposed (3.0±1.8 yrs) sub-
jects. There was no difference between moderately and
severely exposed nonsmokers.
Correlation of BAL inflammatory cells with pulmonary
function (table 2)
The percentage of neutrophils in BAL had a signifi-
cant negative correlation with FEV1 % pred and FEV1/
FVC %. The number of absolute neutrophils in BAL
had a significant negative correlation with FVC % pred
and FEV1 % pred (fig. 3). The number of absolute lym-
phocytes in BAL had a significant negative correlation
with FVC % pred (fig. 4), and FEV1 % pred. In non-
smokers, the percentage of neutrophils in BAL had a
significant negative correlation with FEV1 % pred and




















Fig. 3.  –  Correlation of lung neutrophils with FEV1 % predicted.  
❍ : mild exposure; ∆: moderate exposure; ■: severe exposure (non-
smoker); ❏: severe exposure (smoker). FEV1: forced expiratory vol-




















Fig. 4.  –  Correlation of lung lymphocytes with FVC % predicted.   
❍ : mild exposure; ∆: moderate exposure; ■: severe exposure (non-
smoker); ❏: severe exposure (smoker). FVC: forced vital capacity.
The solid line represents the line of regression.
Table 2.  –  Spearman's rank correlation (rs) of BAL inflammatory cells with pulmonary function
BAL findings FVC % pred FEV1 % pred FEV1/FVC
All Non- Smokers All Non- Smokers All Non- Smokers
subjects smokers subjects smokers subjects smokers
(n=60) (n=50) (n=10) (n=60) (n=50) (n=10) (n=60) (n=50) (n=10)
Total cells -0.183 -0.256 0.152 -0.125 -0.181 0.237 0.069 0.099 0.224
Macrophages
% 0.127 0.322* 0.432 0.152 0.433** 0.592 0.066 0.268 0.183
Absolute -0.095 -0.143 0.182 -0.043 -0.086 0.292 0.096 0.130 0.261
Lymphocytes
% -0.236 -0.259 -0.049 -0.237 -0.222 -0.309 -0.082 -0.020 -0.689*
Absolute -0.273* -0.318* 0.061 -0.258* -0.258 -0.201 -0.051 0.026 -0.657
Neutrophils
% -0.158 -0.083 -0.540 -0.354** -0.350* -0.409 -0.279* -0.378** 0.295
Absolute -0.296* -0.205 -0.627 -0.410** -0.374** -0.437 -0.173 -0.238 0.518
Eosinophils
% -0.024 0.044 -0.202 -0.181 -0.150 -0.046 -0.216 -0.233 0.370
Absolute 0.001 0.028 -0.009 -0.150 -0.157 -0.165 -0.185 -0.214 -0.035
BAL: bronchoalveolar lavage; FVC: forced vital capacity; FEV1: forced expiratory volume in one second; % pred: percentage
of predicted value. *: <0.05; **: <0.01.
FEV1/FVC %. The absolute number of neutrophils in
BAL had a significant negative correlation with FEV1
% pred. The absolute number of lymphocytes had a sig-
nificant negative correlation with FVC % pred. The per-
centage of alveolar macrophages had a significant positive
correlation with FVC % pred, and FEV1 % pred. Total
cell numbers and eosinophils did not have any rela-
tionship with pulmonary function.
Relationship of radiographic findings with BAL cells
and pulmonary function
Stepwise logistic regression of radiographic findings
with pulmonary function revealed that radiographic ab-
normalities were associated with reductions in FEV1 %
pred (p<0.05). The relative risk of having radiographic
abnormality in persons with abnormal FEV1 (<75% pred)
was about five times higher than in those with normal
FEV1 (>75% pred). There is also a suggestion that radio-
graphic abnormalities were associated with an increase
in BAL neutrophils (p=0.07), though it did not attain
statistical significance.
When data were analysed using multiple regression,
there was no relationship between time elapsed since
exposure and the outcome (BAL cells and pulmonary
function), except for eosinophils. The r-values for time
elapsed since exposure were 0.132 (p>0.2) with FEV1/
FVC %, 0.155 (p>0.2) with neutrophils, and 0.300
(p=0.02) with eosinophils.
Discussion
The persistence of clinical, radiological and pulmonary
function abnormalities, as well as neutrophilic alveolitis
and abnormally elevated fibronectin levels in a propor-
tion of subjects suggests the possibility that progressive
lung damage could have occurred in subjects exposed
to toxic gas at Bhopal [2]. Even though we were not
able to measure the quantity of gas inhaled by each sub-
ject in order to classify the severity of exposure, the
finding of an increase in total lung inflammatory cells
recovered by BAL as the severity of exposure increased
suggests that the classification adopted in this study was
reasonably good. This finding further suggests that inten-
sity of lung inflammation is greater in severely exposed
subjects and, hence, the injury resulting from the inflam-
mation and its sequelae will be more pronounced in sub-
jects with severe exposure. This has been further supported
by the fact that impairment in pulmonary function was
more pronounced in severely exposed subjects.
This study has revealed that pulmonary function mea-
surements, such as FVC % pred, FEV1 % pred and FEV1/
FVC %, have significant negative correlations with lower
respiratory tract lymphocytes and neutrophils and this
finding was independent of smoking habits. Therefore,
the considerable respiratory morbidity observed in a group
of toxic gas exposed subjects [11, 12] may be due to
the deleterious effects of lymphocytes and neutrophils
on the lung. Therefore, the progression from the macro-
phagic alveolitis observed in the subacute phase [1] to
neutrophilic alveolitis as time passed [2] is an ominous
sign. The observation that radiographic abnormalities
are associated with decline in pulmonary function and
the suggestion that these abnormalities are higher in
patients with lung neutrophilia (though not significant)
point to the possibility that abnormal accumulation of
neutrophils in the lung can result in irreparable lung
damage. Similar to our findings in gas exposed victims,
MEYER and ZIMMERMAN [13] demonstrated that cystic
fibrosis patients with elevated neutrophils in BAL fluid
had a lower FEV1, suggesting that the continuous pres-
ence of neutrophils contributes to progressive lung dam-
age. The finding of a significant negative correlation of
lymphocytes in nonsmokers with dynamic lung volumes
(FVC % pred) in this study may suggest that lympho-
cytes are associated with lung injury and subsequent
decline in pulmonary function, and this is similar to the
observation of the association of BAL lymphocytosis
with alveolar septal inflammation in patients with idio-
pathic pulmonary fibrosis [14]. Thus, it is possible that
both bronchial and interstitial diseases could occur in
patients exposed to toxic gas at Bhopal. We have noticed
a relationship between the time elapsed since exposure
and eosinophilia. It had been reported previously that
BAL eosinophilia in idiopathic pulmonary fibrosis was
associated with advanced disease [14], and with a poor
response to corticosteroids [15]. Thus, the appearance
of lung eosinophilia in gas-exposed subjects as time
passes may suggest the possibility of the development
of advanced disease and nonresponsiveness to treat-
ment.
It has previously been shown in chronic obstructive
pulmonary disease (COPD) that mortality was signifi-
cantly greater among subjects with obstructive ventila-
tory defect (patients with lower FEV1/FVC %, and FEV1
% pred) [16, 17]. Therefore, the accumulation of neu-
trophils in the lung of toxic gas exposed subjects as time
passed and its negative correlation with FEV1 % pred
and FEV1/FVC % in this study may suggest the possi-
bility of significant respiratory morbidity and early mor-
tality in subjects exposed to toxic gas, especially in those
severely exposed. These findings may further suggest
that simple spirometric measurements, such as FVC and
FEV1, can be utilized as a marker for objective assess-
ment of respiratory morbidity in gas-exposed subjects.
Since lung neutrophilia in these patients is associated
with a decline in FEV1, there is also a possibility that
a proportion of them may develop hyperreactive air-
ways leading to asthma-like syndrome, as it had been
demonstrated that single massive exposure to irritant
gases could result in reactive airways dysfunction syn-
drome [18]. A careful follow-up of the progression of
these patients is essential.
In conclusion, this study suggests that the persisting
pulmonary function abnormalities in patients exposed
to toxic gas at Bhopal may be due to the consequences
of an abnormal accumulation of lung inflammatory cells
(lymphocytes and neutrophils) and that serious abnor-
malities of pulmonary function occur in patients who
had severe exposure to the gas. There is also a sugges-
tion that the lung damage following toxic gas exposure
can be irreversible, as it has been demonstrated that
decline in pulmonary function is associated with radi-
ographic abnormalities.
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